Association between physician characteristics and likelihood of caring for underserved patients with cancer.

W William Roberts (Department of Chemistry, Brown University 1 , Providence, Rhode Island 02912,) P Pamela Soulos (Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale School of Medicine, New Haven, CT) J Jeph Herrin (Yale School of Medicine, New Haven, CT) J Jessica B. Long (Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale School of Medicine, New Haven, CT) I Inginia Genao (Penn State College of Medicine, Hershey, PA) C Craig Evan Pollack (Johns Hopkins Bloomberg School of Public Health and School of Nursing, Baltimore, MD) J James B. Yu (Department of Radiation Oncology and Applied Sciences, Dartmouth Hitchcock Medical Center, Lebanon, NH) D Dowin H. Boatright (NYU Grossman School of Medicine, New York, NY) C Cary Philip Gross (National Clinician Scholars Program; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center; Yale School of Medicine, New Haven, CT)

Abstract

1646 Background: Despite evidence that a diverse workforce may improve access to care for underserved patients, emerging policies threaten to limit diversity in the physician workforce. We assessed whether nonwhite and foreign-born physicians were more likely than White and US-born physicians to care for underserved (minority race, low-income, rural) Medicare beneficiaries with cancer. Methods: Using SEER-Medicare, we analyzed Medicare beneficiaries aged 18+ newly diagnosed with breast, colorectal, lung, or prostate cancer from 2015-2019. We linked patients to cancer physicians (medical, radiation, and surgical oncology) using claims in the 6 months after diagnosis. We assessed physician race/ethnicity (data from Association of American Medical Colleges) and country of birth (American Medical Association). For each physician race and foreign-born status, we calculated the standardized treatment ratio (STR) as the percent of that group's dyads with a given patient characteristic divided by the percent of all dyads with that patient characteristic. Thus, STR > 1 indicates physicians in that group are more likely than the average physician to treat patients with the given characteristic. Results: We linked 434,923 patients (30% breast, 16% colorectal, 29% lung, 25% prostate) to 35,257 physicians. The patient population (mean age 74.7) was 79% White, 8% Black, 7% Hispanic, 3% Asian, 17% Medicaid dual-eligible, and 16% rural. Black physicians were more likely than expected to care for Black patients (STR 2.55; 95% CI 2.48–2.63; Table) and dual-eligible patients (STR 1.26; 1.22–1.29). Hispanic physicians were more likely to care for Hispanic (1.97; 1.91–2.03) and dual-eligible (1.11; 1.08–1.14) patients. Asian physicians were more likely to care for Asian (1.93; 1.89–1.96) and Hispanic (1.18; 1.16–1.20) patients and less likely to care for rural (0.73; 0.72-0.74) patients. Foreign-born physicians (20.7% of physicians) were more likely to care for Asian (1.36; 1.33–1.39), Hispanic (1.25; 1.23–1.27), and dual-eligible (1.20; 1.18–1.21) patients and less likely to care for rural patients (0.90, 0.89-0.91). Conclusions: Nonwhite and foreign-born cancer physicians disproportionately care for nonwhite and low-income patients. Policies restricting entry of minority and foreign-born physicians into the oncology workforce may hinder access to care for underserved cancer patients. Standardized treatment ratios (STRs) by physician race, ethnicity and country of birth. Physician characteristic Patient Characteristic Asian Black Hispanic White Dual eligible Rural Race & ethnicity  Asian 1.93 1.00* 1.17 0.95 1.09 0.73  Black 0.60 2.55 1.08 0.85 1.26 1.04  Hispanic 0.79 0.97* 1.97 0.94 1.11 1.01*  White 0.68 0.92 0.81 1.04 0.88 1.09 Foreign born  No 0.86 0.96 0.89 1.02 0.88 1.04  Yes 1.36 1.05 1.25 0.96 1.20 0.90 *Denotes STRs NOT significantly different from 1.0; all other values are significant (P<0.05).

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 1646-1646
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (9)

W

William Roberts

Department of Chemistry, Brown University 1 , Providence, Rhode Island 02912,

P

Pamela Soulos

Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale School of Medicine, New Haven, CT

J

Jeph Herrin

Yale School of Medicine, New Haven, CT

J

Jessica B. Long

Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale School of Medicine, New Haven, CT

I

Inginia Genao

Penn State College of Medicine, Hershey, PA

C

Craig Evan Pollack

Johns Hopkins Bloomberg School of Public Health and School of Nursing, Baltimore, MD

J

James B. Yu

Department of Radiation Oncology and Applied Sciences, Dartmouth Hitchcock Medical Center, Lebanon, NH

D

Dowin H. Boatright

NYU Grossman School of Medicine, New York, NY

C

Cary Philip Gross

National Clinician Scholars Program; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center; Yale School of Medicine, New Haven, CT